immune-checkpoint

Documents about immune-checkpoint

• Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients#874427ClinicalTrials.gov
• Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy#356476ClinicalTrials.gov
• ICOS-ImmunoPET Monitors T Cell Activation After Combination Immune Checkpoint Blockade in a Mouse Model of Melanoma Brain Metastasis.#458623NCBI PubMed Central
• Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma#474778ClinicalTrials.gov
• Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain Metastases#481763ClinicalTrials.gov
• Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma#803882ClinicalTrials.gov
• OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease#812322ClinicalTrials.gov
• The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities#842149ClinicalTrials.gov
• Fecal Microbiota Transplantation to Improve Efficacy of Immune Checkpoint Inhibitors in Renal Cell Carcinoma#864397ClinicalTrials.gov
• Stool Transplant to Control Treatment-related Diarrhea#870495ClinicalTrials.gov
• Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma#967007ClinicalTrials.gov
• Analysis of Efficacy and Outcomes of Immunotherapy for Malignant Tumors: A Prospective Non-interventional Clinical Study#979049ClinicalTrials.gov
• Clinical Research on the Use of Immune Checkpoint Inhibitors Combined With Chidamide for the Functional Cure of AIDS#1045746ClinicalTrials.gov
• R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors#908775ClinicalTrials.gov
• Table 1_Global research trends and emerging frontiers of intratumoral microbiota in cancer immunotherapy: a bibliometric and visualization analysis.docx#384349Figshare
• SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer#18604ClinicalTrials.gov
• PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer#121352ClinicalTrials.gov
• Highly activated CD4+ T regulatory cells associated with non- responders to immune-checkpoint inhibitors in metastatic melanoma#130420Unpaywall
• Immune Checkpoint Therapy Drives Maturation of a Cellular Neighborhood Nucleated by T Cell-APC Triads Enabling Spatially Compartmentalized Tumor Immunity#172219bioRxiv / medRxiv
• Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors#326130HAL (France)
• Defining the Role of the Skin Microbiome in Immune-related Adverse Events#802183ClinicalTrials.gov
• Trial of Pulsed Electric Field Therapy in Patients With Late-stage Non-small Cell Lung Cancer#832663ClinicalTrials.gov
• Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer#898078ClinicalTrials.gov
• Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer#910028ClinicalTrials.gov
• Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC#995419ClinicalTrials.gov
• Prospective Study to Evaluate the Blood Kinetics of Immune Cells and Immunosuppressive Cytokines After Exposure to an Immunity Checkpoint Inhibitor (ICI): Study of the Impact of Chemotherapy#900704ClinicalTrials.gov
• Gene-level gut microbiome signatures as predictive biomarkers for response to immune checkpoint inhibitors across multiple cancer types#140164Unpaywall
• Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer#287559ClinicalTrials.gov
• Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC#417561ClinicalTrials.gov
• Kidney VISTA prevents IFN-gamma/IL-9 axis-mediated tubulointerstitial fibrosis after acute glomerular injury#439903S-Space: Seoul National University
• Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)#444883ClinicalTrials.gov
• Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients#454034ClinicalTrials.gov
• A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer#467568ClinicalTrials.gov
• Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation#803326ClinicalTrials.gov
• Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma#860409ClinicalTrials.gov
• SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma#1047748ClinicalTrials.gov
• Table 1_Efficacy and safety of combined immune therapy for advanced cervical cancer: a systematic review and meta-analysis.docx#222486Figshare
• More than age: Impact of comorbidity and polypharmacy on immune-related adverse events, treatment discontinuation, and toxicity management in older patients receiving immune checkpoint inhibitors / Anja Gesierich, Eran Demeter, Bastian Schilling, Barbara Deschler-Baier#1015032Deutsche Nationalbibliothek
• Liver Cancer and Immunotherapy in the Liquid Biopsy Era#208450ClinicalTrials.gov
• Data Management and Sharing Plan for: Identifying cellular and molecular signatures from distinct T cell receptor clonotypes associated with favorable immune checkpoint inhibitor responses in HNSCCs#282026UNC Dataverse Dataverse OAI Archive
• Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft Rejection#283057ClinicalTrials.gov
• The clinical value of adding immune checkpoint inhibitors to radiotherapy for cancer: a systematic review and meta-analysis#676304Europe PMC
• Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma#811889ClinicalTrials.gov
• Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer#812014ClinicalTrials.gov
• A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors#902710ClinicalTrials.gov
• Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer#907930ClinicalTrials.gov
• Baseline C-reactive protein independently predicts treatment response and survival in metastatic melanoma patients receiving first-line immune checkpoint inhibitors#1028844Bielefeld Pub
• Non-pharmacological supportive care interventions during immunotherapy for people with cancer: A systematic scoping review and future directions#977228Research Online
• Immune checkpoint inhibitors in children with replication-repair-deficient high-grade gliomas. The South London Paediatric & TYA Neuro-Oncology Network experience#4876Europe PMC
• COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research#172401ClinicalTrials.gov